Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 4,929

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial

·1999·The Lancet

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(98)11181-9

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 18

  1. Waagstein, 1975, Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy, Br Heart J, 37, 1022, 10.1136/hrt.37.10.1022 · DOI
  2. 1998, 3-year follow-up of patients randomised in the Metoprolol in Dilated Cardiomyopathy Trial, Lancet, 351, 1180, 10.1016/S0140-6736(05)79125-X · DOI
  3. 1997, Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease, Lancet, 349, 375, 10.1016/S0140-6736(97)80008-6 · DOI
  4. Doughty, 1997, Effects of beta-blocker therapy on mortality in patients with heart failure: a systematic overview of randomised controlled trials, Eur Heart J, 8, 560, 10.1093/oxfordjournals.eurheartj.a015297 · DOI
  5. Heidenrich, 1997, Effect of beta-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials, J Am Coll Cardiol, 30, 27, 10.1016/S0735-1097(97)00104-6 · DOI
  6. Lechat, 1998, Beta-blockers in heart failure: meta-analysis of randomized trials, Circulation, 98, 1184, 10.1161/01.CIR.98.12.1184 · DOI
  7. Haeusler, 1986, High β1 selectivity and favourable pharmacokinetics as the outstanding properties of bisoprolol, J Cardiovasc Pharmacol, 8, S2
  8. 1994, A randomized trial of β-blockade in heart failure: the Cardiac Insufficiency Bisoprolol Study (CIBIS), Circulation, 90, 765
  9. 1997, Design of the Cardiac Insufficiency Bisoprolol Study II (CIBIS II), Fund Clin Pharmacol, 11, 38
  10. Peto, 1976, Design and analysis of randomised clinical trials requiring prolonged observation of each patient, I: introduction and design, Br J Cancer, 34, 585, 10.1038/bjc.1976.220 · DOI · Paper page
  11. Garg, 1995, Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure, JAMA, 273, 1450, 10.1001/jama.1995.03520420066040 · DOI · Paper page
  12. Gottlieb, 1998, Effect of beta-blockade on mortality among high risk and low risk patients after myocardial infarction, N Engl J Med, 339, 489, 10.1056/NEJM199808203390801 · DOI
  13. Packer, 1996, The effect of carvedilol on morbidity and mortality in patients with chronic heart failure, N Engl J Med, 334, 1349, 10.1056/NEJM199605233342101 · DOI · Paper page
  14. Pousset, 1996, Effects of bisoprolol on heart rate variability in heart failure, Am J Cardiol, 77, 612, 10.1016/S0002-9149(97)89316-2 · DOI
  15. Copie, 1996, Effects of beta-blockade with bisoprolol on heart rate variability in advanced heart failure: analysis of scatterplots of RR intervals at selected heart rates, Am Heart J, 132, 369, 10.1016/S0002-8703(96)90435-4 · DOI
  16. Bristow, 1996, Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure, Circulation, 4, 2807, 10.1161/01.CIR.94.11.2807 · DOI · Paper page
  17. Lechat, 1997, Prognostic value of bisoprolol-induced hemodynamic effects in heart failure during the Cardiac Insufficiency Bisoprolol Study, Circulation, 96, 2197, 10.1161/01.CIR.96.7.2197 · DOI
  18. 1995, Design of the Beta-blocker Evaluation Survival Trial, Am J Cardiol, 5, 1220

Cited by

See all 4,929

Metadata

Venue
The Lancet
Publisher
Elsevier BV
Published
1999-01
Volume
353
Issue
9146
Pages
9-13
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2296998040
Cited by
4,929
References
2
FWCI
214.79
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.